These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19945058)

  • 1. Pharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.
    Liggett SB
    Heart Fail Clin; 2010 Jan; 6(1):27-33. PubMed ID: 19945058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker pharmacogenetics in heart failure.
    Shin J; Johnson JA
    Heart Fail Rev; 2010 May; 15(3):187-96. PubMed ID: 18437562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.
    de Groote P; Helbecque N; Lamblin N; Hermant X; Mc Fadden E; Foucher-Hossein C; Amouyel P; Dallongeville J; Bauters C
    Pharmacogenet Genomics; 2005 Mar; 15(3):137-42. PubMed ID: 15861037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
    Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
    Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
    Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
    PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.
    Dorn GW; Liggett SB
    Clin Transl Sci; 2008 Dec; 1(3):255-62. PubMed ID: 20443857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.
    Dorn GW; Liggett SB
    Mol Pharmacol; 2009 Sep; 76(3):466-80. PubMed ID: 19491328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.
    Lymperopoulos A; Negussie S; Walklett K
    Pharmacogenomics; 2013 Oct; 14(13):1545-9. PubMed ID: 24088125
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.
    Liggett SB; Mialet-Perez J; Thaneemit-Chen S; Weber SA; Greene SM; Hodne D; Nelson B; Morrison J; Domanski MJ; Wagoner LE; Abraham WT; Anderson JL; Carlquist JF; Krause-Steinrauf HJ; Lazzeroni LC; Port JD; Lavori PW; Bristow MR
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11288-93. PubMed ID: 16844790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Beta1 -Adrenergic Receptor Polymorphism and Risk of ICD Shock in Heart Failure Patients.
    Zanolla L; Guarise P; Tomasi L; Vassanelli C; Cicorella N; Zanini R; Guarrera S; Fiorito G; Matullo G
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):557-64. PubMed ID: 27027728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
    O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
    PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure patients with B1-adrenoreceptor polymorphisms have augmented carvedilol response as detected by cardiac I123-MIBG scintigraphy.
    Miranda SM; Moscavitch SD; Pereira SB; de Azevedo JC; Messias LR; Rodrigues RC; Mesquita ET; Ribeiro GS; Mesquita CT
    Int J Cardiol; 2014 Nov; 177(1):111-3. PubMed ID: 25499350
    [No Abstract]   [Full Text] [Related]  

  • 20. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.